BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32187106)

  • 1. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
    Fattahi F; Zetoune FS; Ward PA
    Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Complement and Histones in Sepsis.
    Zetoune FS; Ward PA
    Front Med (Lausanne); 2020; 7():616957. PubMed ID: 33425963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of complement C5a and histones in septic cardiomyopathy.
    Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
    Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for treatment of infectious sepsis.
    Ward PA; Fattahi F
    J Leukoc Biol; 2019 Jul; 106(1):187-192. PubMed ID: 30821872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
    Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
    J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE IMMUNOPATHOGENESIS OF POLYMICROBIAL SEPSIS.
    Zetoune FS; Ward PA
    Shock; 2023 Feb; 59(2):311-317. PubMed ID: 36377404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dark side of C5a in sepsis.
    Ward PA
    Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and sepsis-induced heart dysfunction.
    Fattahi F; Ward PA
    Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
    Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
    J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
    Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
    Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
    Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.